Aclarion Corporation - רווח נקי למניה ב-12 החודשים האחרונים ACON
The investment potential of Aclarion (ACON) is based on unique MRI spectroscopy algorithms that require extensive validation. The annual EPS (TTM) growth statistics visualize this process, where the value of 99.80 corresponds to the current metric. The foundation is built by competent managers striving to integrate software into US insurance systems, as well as the full automation of NociScan, which allows AI to autonomously identify sources of pain.
Aclarion, Inc. - פילוחים אנליטיים ומדדי מפתח (ACON)
An analysis of Aclarion (ACON) via trailing twelve-month (TTM) EPS growth statistics reveals the dynamics of net profit per share over a rolling year. This indicator captures the percentage change in earnings, incorporating daily market liquidity to determine fundamental momentum. The metric's high sensitivity to one-off shifts necessitates an evaluation of the overall trend rather than isolated data points. For a company whose specialized software is shielded from US geopolitical risks, this figure reflects pure operational growth. A stable earnings trajectory confirms the resilience of the business model within a neutral regulatory environment.
